Literature DB >> 7561039

Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response.

P R Walker1, T Ohteki, J A Lopez, H R MacDonald, J L Maryanski.   

Abstract

We have previously described a unique system for identifying Ag-selected CD8 T cells during an in vivo response in normal mice. In this system, lymphocytes isolated from DBA/2 mice injected i.p. with HLA-CW3 transfected syngeneic (H-2d) P815 cells show a remarkable expansion of CD8 cells that utilize TCR expressing the V beta 10 gene segment and additional structural features characteristic of Kd-restricted CW3-specific CTL clones. We have now taken advantage of this system to characterize the surface phenotype of CD8 cells selected by Ag in vivo. We observed several distinct phenotypes at different stages of the response. At the peak of the response, Ag-selected cells were low in CD62L and CD45RB expression but displayed high levels of CD44. In addition, there was a partial down-regulation of CD8 and TCR. Cells of this phenotype were present in lymphoid tissues for several mo after immunization. Much later in the response, Ag-selected cells expressed higher levels of CD8 and TCR. Moreover, a distinct subset of these long-term immune cells emerged that now expressed CD62L and CD45RB. Analysis of CD8 cells from different tissues also revealed certain differences, particularly in TCR and co-receptor levels from liver-derived cells compared with circulating cells at the peak of the response. Our findings suggest that the function of Ag-selected CD8 cells may be regulated over time and according to location by subtle changes in cell-surface phenotype.

Entities:  

Mesh:

Year:  1995        PMID: 7561039

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Comparative T cell receptor repertoire selection by antigen after adoptive transfer: a glimpse at an antigen-specific preimmune repertoire.

Authors:  V Attuil; P Bucher; M Rossi; M Mutin; J L Maryanski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 2.  Individuality of Ag-selected and preimmune TCR repertoires.

Authors:  J L Maryanski; V Attuil; A Hamrouni; M Mutin; M Rossi; A Aublin; P Bucher
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Multiple T-cell clones specific for the same foreign pMHC ligand can be generated from a single, ancestral TCR-VDJbeta precursor.

Authors:  Janet L Maryanski; Anne Aublin; Valérie Attuil-Audenis; Abdelbasset Hamrouni
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

4.  Phenotypic changes in T cell populations during the reactivation of tuberculosis in mice.

Authors:  A D Howard; O J Trask; S E Weisbrode; B S Zwilling
Journal:  Clin Exp Immunol       Date:  1998-02       Impact factor: 4.330

5.  Functional differences between memory and naive CD8 T cells.

Authors:  B K Cho; C Wang; S Sugawa; H N Eisen; J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

6.  Hierarchal utilization of different T-cell receptor Vbeta gene segments in the CD8(+)-T-cell response to an immunodominant Moloney leukemia virus-encoded epitope in vivo.

Authors:  P Brawand; J C Cerottini; H R MacDonald
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

7.  T-cell activation, proliferation, and memory after cardiac transplantation in vivo.

Authors:  N D Jones; A Van Maurik; M Hara; B J Gilot; P J Morris; K J Wood
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

8.  Switch from perforin-expressing to perforin-deficient CD8(+) T cells accounts for two distinct types of effector cytotoxic T lymphocytes in vivo.

Authors:  Avihai Meiraz; Orit Gal Garber; Shaul Harari; David Hassin; Gideon Berke
Journal:  Immunology       Date:  2009-09       Impact factor: 7.397

9.  The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection.

Authors:  M K Maini; C Boni; C K Lee; J R Larrubia; S Reignat; G S Ogg; A S King; J Herberg; R Gilson; A Alisa; R Williams; D Vergani; N V Naoumov; C Ferrari; A Bertoletti
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

10.  Hydroxychloroquine (HCQ) decreases the benefit of anti-PD-1 immune checkpoint blockade in tumor immunotherapy.

Authors:  Janna Krueger; Francois Santinon; Alexandra Kazanova; Mark E Issa; Bruno Larrivee; Richard Kremer; Catalin Milhalcioiu; Christopher E Rudd
Journal:  PLoS One       Date:  2021-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.